An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancer

Overview of attention for article published in Frontiers in immunology, January 2024

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

twitter: 5 X users

Readers on

mendeley: 5 Mendeley

Summary X

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 33,546 followers.

RT @Salihlab: Glad to share that our latest publication! Congrats to all authors, in particularly Martina Lutz and Ilona Hagelstein for spe…

29 Jan 2024

Reply Repost Favourite

Glad to share that our latest publication! Congrats to all authors, in particularly Martina Lutz and Ilona Hagelstein for spearheading this work! #PancreaticCancer #Immunotherapy

29 Jan 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancer: Pancreatic cancer is a…

22 Jan 2024

Reply Repost Favourite

RT @FrontImmunol: New Research: An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancer: Pancreatic cancer is a…

22 Jan 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.